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Abstract
Background: Serum feline pancreatic lipase immunoreactivity (fPL) commonly is used
in the assessment of sick cats suspected to have pancreatitis but its diagnostic utility is
debated.
Objectives: To evaluate the diagnostic utility of the Spec fPL test and selected serum
biochemistry tests in the diagnosis of pancreatitis in cats.
Animals: Two hundred seventy-four client-owned cats presented to a university
teaching hospital in the United Kingdom, from April 2013 to May 2017, in which
Spec fPL was measured.
Methods: Cats were classified into 1 of 4 groups based on clinical signs (all cats),
ultrasonographic findings (all cats) and histopathological or cytological assessment of
the pancreas where available (9 cats) regardless of Spec fPL concentration. The
groups were (a) definite pancreatitis (n = 9), (b) probable pancreatitis (n = 49), (c) possi-
ble pancreatitis (n = 139), and (d) unlikely pancreatitis (n = 77). Spec fPL and selected
serum biochemistry test results were compared among groups.
Results: Serum fPL concentrations >5.3 μg/L were classified as positive and concen-
trations <3.5 μg/L were classified as negative. There was a significantly (P = .03)
lower proportion of false-positive results (cats unlikely to have pancreatitis, n = 77,
with a positive fPL, n = 8, 10%) than false-negative results (cats with definite or prob-
able pancreatitis, n = 58, with a negative fPL result, n = 14, 24%). None of the
selected biochemical tests were helpful diagnostically.
Conclusion and Clinical Importance: A positive Spec fPL result indicates that pancre-
atitis is a probable diagnosis, but the test cannot be used to rule the diagnosis out.
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1 | INTRODUCTION
Pancreatitis is relatively common in cats. However, reaching a defini-
tive diagnosis is challenging because of the nonspecific clinical
signs,1,2 the variable sensitivity and specificity of the diagnostic tests
available,3 and the challenge of finding a gold standard diagnostic test
Abbreviations: ALP, alkaline phosphatase; ALT, alanine aminotransferase; fPL, feline
pancreatic lipase.
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against which other diagnostic tests can be assessed. Nonspecific clin-
ical signs of pancreatitis in cats include anorexia, lethargy, vomiting,
diarrhea, dehydration, abdominal pain, abdominal distension, weight
loss, and pyrexia.1,3,4
Diagnosis of pancreatitis in cats usually involves a combination of
clinical suspicion, evaluation of clinical pathology test results, ultraso-
nographic evidence of pancreatitis, and measurement of serum feline
pancreatic lipase immunoreactivity (fPL).1,5 Because no gold standard
diagnostic test is available, clinicians must assess test results critically
in the context of the clinical presentation.6
Lipase is secreted by several tissues and hence measuring the
total serum activity of this enzyme is of no diagnostic value in the
diagnosis of pancreatitis in cats.2 Pancreatic lipase, however, is exclu-
sively secreted by the pancreas.6,7 This was demonstrated in dogs,
because dogs with exocrine pancreatic insufficiency had no canine
pancreatic lipase immunoreactivity (cPL) in their serum.8,9 However,
no similar study has been reported in cats.7 Regardless, the amino acid
sequence of feline pancreatic lipase should be different from that of
lipase secreted by other tissues, which in turn should generate a spe-
cific immunologic response.9 The IDEXX laboratories developed the
Spec fPL, a quantitative ELISA in 2008 for feline PL, as they had for
the canine Spec cPL.6
Clinical pathology results reported in cats with pancreatitis include
hyperbilirubinemia, hypocalcemia, and hypoalbuminemia, but there are
conflicting reports on whether or not clinically relevant differences in
these variables occur in cats with pancreatitis.3,6
Our aims were to evaluate the diagnostic utility of the Spec fPL
test and selected biochemical tests in the diagnosis of pancreatitis in
cats presented to a small animal referral teaching hospital in the
United Kingdom. Because no gold standard to assess the diagnostic
performance of Spec fPL is available,2 a combination of diagnostic
findings (clinical signs and ultrasonography in all cats, histopathology
and cytology in some cats) was used to reach a diagnosis of definite,
probable, possible, or unlikely pancreatitis.
2 | MATERIALS AND METHODS
2.1 | Animals
The Spec fPL results for 300 client-owned cats admitted to a
referral teaching hospital in the United Kingdom between April
2014 and May 2017 were obtained from the records of the hospi-
tal's veterinary diagnostic laboratory. Inclusion criteria for the study
were all cats in which Spec fPL was measured, for which signalment
and description of clinical signs at the time of blood sampling were
recorded, and that had ultrasonographic assessment of the pancreas
performed by a board-certified specialist or supervised resident in
diagnostic imaging in the teaching hospital. Twenty-six cats that did
not have an abdominal ultrasound examination performed were
excluded.
The study was approved by the Social Science Research Ethical
Review Board at the teaching hospital (URN number: SR2017-1073).
2.2 | Recording and data collection
The clinical records for all cats were reviewed and the following vari-
ables associated with the specific visit at which fPL was measured were
recorded: signalment (age, breed, sex, and neuter status), presenting
clinical signs, selected biochemistry test results (alanine aminotransfer-
ase [ALT] and alkaline phosphatase [ALP] activities, serum albumin, total
calcium and bilirubin concentrations), and abdominal ultrasound find-
ings, focusing on the pancreas, biliary system, and peritoneum.
Keywords that reflect the ultrasonographic changes reported for
cats in the definite and probable pancreatitis groups were hypoechoic,
enlargement, thickened, irregular margins, and hyperechoic perip-
ancreatic fat.10
If available, the appearance of the pancreas at exploratory lapa-
rotomy, pancreatic cytology or histopathology, and the findings at
necropsy were recorded.
Keywords that reflected the visual changes seen in cats in the defi-
nite pancreatitis group were firm, nodular, congested, duct distension,
inflamed, and edematous. Keywords that reflected the histopathological
or cytological changes seen in the definite pancreatitis group were lym-
phocytic or neutrophilic inflammation or both, necrosis, edema, and
hemorrhage.
2.3 | Classification of cases
Each case was categorized into 1 of 4 groups: (a) definite pancreatitis,
(b) probable pancreatitis, (c) possible pancreatitis, and (d) unlikely pan-
creatitis regardless of the concentration of the Spec fPL according to
the criteria described below (Table 1).
In cats categorized as definite pancreatitis, all clinical signs and
clinical pathology test results could be explained by pancreatitis, and
no other identified concurrent disease was present that could explain
the clinical signs. They had ultrasonographic changes consistent with
pancreatitis and had cytological or histopathologic changes in pancre-
atic biopsy specimens, visible changes in the pancreas at exploratory
laparotomy or necropsy examination or both.
In cats categorized as probable pancreatitis, all clinical signs and
clinical pathology test results could be explained by pancreatitis and
no other identified concurrent disease was present that could explain
the clinical signs. They had ultrasonographic changes consistent with
pancreatitis. No visual, cytological, or histological examination of the
pancreas was performed.
In cats categorized as possible pancreatitis, most clinical signs and
history could be explained by pancreatitis. However, they had no
ultrasonographic evidence for pancreatitis and no visual, cytological,
or histological examination of the pancreas was performed.
For cats categorized as unlikely pancreatitis, the clinical signs and his-
tory could be explained by pancreatitis but another disease was present
that could explain the presenting signs (eg, hypertrophic cardiomyopathy,
renal disease, gastrointestinal neoplasia). No ultrasonographic evidence
for pancreatitis was present and no visual, cytological, or histological
examination of the pancreas was performed.
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2.4 | Statistical analysis
The Spec fPL concentrations were not normally distributed (D'Agostino
and Pearson normality test) and therefore nonparametric statistical
analysis was performed. Median Spec fPL concentrations for each
group were compared using the Kruskal-Wallis test followed by Dunns
multiple comparisons test if a significant difference was detected.
Chi-squared analysis was used to compare the proportion of positive
(>5.3 μg/L) and negative (<3.6 μ/L) fPL results in each group.
Serum albumin, total bilirubin and calcium concentrations and
ALT and ALP activities were analyzed among groups by using the
Kruskal-Wallis test followed by Dunns multiple comparisons test if a
significant difference between groups was detected. The relationship
between Spec fPL and bilirubin concentrations was assessed by using
Pearson correlation.
Statistical tests were performed by using the GraphPad Prism
Version 7.00. Significance was defined as P < .05. Comparison of pro-
portions test was performed by using the MedCalc statistical soft-
ware, which uses the “N-1” Chi-squared test.
3 | RESULTS
3.1 | Diagnostic classification
Of the 274 cats included in the study, 3.3% (n = 9) were assessed as
having definite pancreatitis, 17.9% (n = 49) as probable pancreatitis,
50.7% (n = 139) as possible pancreatitis, and 28.1% (n = 77) as unlikely
pancreatitis. The inclusion criteria used to classify the cats diagnosti-
cally are described in detail in the Methods section and in Table 1.
3.2 | Study population
Sixty-one percent of the cats were neutered males (n = 167) and all cats
assessed as definite pancreatitis were neutered males (n = 9). Thirty-
seven percent (n = 101) were neutered females with the remaining cats
being intact males (n = 2) or intact females (n = 4). The age of the cats
ranged from 4 months to 19 years (median 2 years) with no significant
difference in median age among the 4 groups (P = .6). The most com-
monly presented breeds included domestic shorthair (56.7%, n = 156),
domestic longhair (6.9%, n = 19), Bengal (4.7%, n = 12), Burmese (4.7%,
n = 13), and British shorthair (4.7%, n = 13). Other breeds included Bir-
man, Siamese, Maine Coon, and Persian. There were >3 times as many
Bengal cats in the definite (11.1%) and probable (10.2%) groups com-
pared to the possible (2.9%) and unlikely (2.6%) groups. Burmese cats
also were overrepresented in the probable (10.2%) group compared
with the possible (3.6%) and the unlikely (3.9%) groups. No Burmese cat
was found in the definite group.
3.3 | Clinical signs
The most common clinical signs reported in all groups were lethargy,
anorexia, vomiting, and weight loss (Table 2). Other clinical signs
noted in all groups were polyuria and polydipsia, abdominal pain, and
pyrexia.
3.4 | Feline pancreatic lipase immunoreactivity
(fPL) concentrations
Spec fPL concentrations in the 274 cats ranged from 0.5 to 50 μg/L
with a median of 2.6 μg/L (Table 3). The median fPL for the definite
group was 12.2 μg/L (range, 0.9-0.38 μg/L), the median for the proba-
ble group was 7.2 μg/L (range, 0.6-0.47 μg/L), the median for the possi-
ble group was 2.7 μg/L (range, 0.5-0.50 μg/L), and the median for the
unlikely group was 1.8 μg/L (range, 0.5-0.20 μg/L). A significant differ-
ence in fPL concentration was found between groups (P < .0001), with
the following groups showing significant differences in concentrations
after multiple comparison tests: definite versus unlikely (P = .007), prob-
able versus possible (P = .0001), probable versus unlikely (P < .0001),
and possible versus unlikely (P = .03; Figure 1). Because no significant
difference was found between the fPL results for cats classified as
TABLE 1 Characteristics used to classify feline cases into definite pancreatitis, probable pancreatitis, possible pancreatitis, and unlikely
pancreatitis
Definite pancreatitis
• All clinical signs and clinical pathology could be explained by
pancreatitis
• Ultrasonographic changes consistent with pancreatitis
• Cytologic or histopathologic changes on pancreatic biopsy
and/or visible changes in the pancreas on exploratory
laparotomy or necropsy examination
Probable pancreatitis
• All clinical signs and clinical pathology could be explained by
pancreatitis
• Ultrasonographic changes consistent with pancreatitis
• No visual, cytological, or histological examination of the
pancreas performed
Possible pancreatitis
• Most clinical signs and history could be explained by pancreatitis
• No ultrasonographic evidence for pancreatitis
• No visual, cytological, or histological examination of the
pancreas performed
Unlikely pancreatitis
• Clinical signs and history could be explained by pancreatitis but
there was presence of another disease that could explain the
presenting signs, for example, hypertrophic cardiomyopathy
(HCM), renal disease, and gastrointestinal neoplasia
• No ultrasonographic evidence for pancreatitis
• No visual, cytological, or histological examination of the
pancreas performed
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definite versus probable pancreatitis, the results were combined for fur-
ther analysis.
The median and range of fPL concentrations for each group are
illustrated in Figure 1. The cutoff for positive, equivocal, and negative
results was based on the reference range for the fPL test (0.7-3.5 μg/
L). Above 5.3 μg/L is considered consistent with pancreatitis and a
result >5.3 μg/L was defined as a positive result. Results between 3.6
and 5.3 μg/L were considered intermediate and were defined as
equivocal. Results ≤3.5 μg/L were defined as negative. The distribu-
tion of fPL results up to 20 μg/L is shown in Figure 2 to more clearly
illustrate the distribution of results in each group <3.5 μg/L (negative
results) and >5.3 μg/L (positive results). The number and proportion of
cats in each fPL category in each group are shown in Table 4.
Chi-squared analysis of the combined definite plus probable, pos-
sible, and unlikely groups showed that a significant difference was
present in the proportion of cats with positive (>5.3 μg/L) and
negative (<3.6 μg/L) fPL results in the groups (P < .0001). There was a
significantly (P = .03) lower proportion of false-positive results (cats
with a positive fPL result of >5.3 μg/L classified as unlikely to have
pancreatitis, 10%; n = 8) compared with false-negative results (cats
with definite or probable pancreatitis with a negative fPL result of
<3.5 μg/L, 24; n = 14).
3.5 | Serum biochemistry
No significant differences were found between combined definite and
probable pancreatitis versus possible and unlikely pancreatitis groups
for serum albumin (P = .4) and total calcium concentrations (P = .1)
and ALT (P = .5) and ALP (P = .25) activities (Table 5).
The overall median total bilirubin concentration was 2.2 μmol/L (ref-
erence range, 0-15 μmol/L). A significant difference in total bilirubin
TABLE 2 The 4 most common clinical signs presented by each of the 3 groups of cats, n = number of cats
Combined definite and probable
pancreatitis (n = 58)
Possible pancreatitis
(n = 139)
Unlikely pancreatitis
(n = 77)
1. Lethargy (75.8%) Anorexia (74.3%) Anorexia (62.3%)
2. Anorexia (66.1%) Lethargy (61%) Weight loss (54.5%)
3. Vomiting (53.2%) Vomiting (51.5%) Lethargy (50.6%)
4. Weight loss (50%) Weight loss (44.9%) Vomiting (33.8%)
TABLE 3 Median, mean, and range of Spec fPL concentrations for each of the 4 groups of cats, n = number of cats
Group Median Spec fPL (μg/L) Mean Spec fPL (μg/L) Range Spec fPL (μg/L)
Definite pancreatitis (n = 9) 12.2 14.7 0.9-38
Probable pancreatitis (n = 49) 7.2 11.9 0.6-47
Possible pancreatitis (n = 139) 2.7 5.8 0.5-50
Unlikely pancreatitis (n = 77) 1.8 2.8 0.5-20
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F IGURE 1 Box and Whiskers plot (median and range) comparing
Spec fPL concentrations in each of the 4 groups of cats (definite
pancreatitis n = 9, probable pancreatitis n = 49, possible pancreatitis
n = 139, unlikely pancreatitis n = 77)
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F IGURE 2 Scatter plot showing the distribution of Spec fPL
concentrations up to 20 μg/L in each of the 4 groups of cats with
reference range cutoff values of positive >5.3 μg/L and negative
<3.6 μg/L. Twenty-one data points are omitted as they were greater
than 20 μg/L (3 definite pancreatitis, 9 probable pancreatitis, and
9 possible pancreatitis)
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concentration was found between the combined definite and probable
pancreatitis group and the possible pancreatitis group (median combined
definite and probable pancreatitis groups, 1.9 μmol/L; possible pancreati-
tis group, 2.5 μmol/L; P = .0005) and between the possible pancreatitis
group and the unlikely pancreatitis group (median unlikely pancreatitis
group = 1.9 μmol/L; P < .0001). No significant difference was found
between the combined definite and probable group and the unlikely
group (P = 1.00). The mean, median and range for the combined definite
and probable, possible, and unlikely pancreatitis groups are shown in
Table 6.
No correlation was found between Spec fPL concentrations and
bilirubin concentrations when concentrations from all of the groups
were compared (r = 0.118, P = .06) nor when the results from the
combined definite pancreatitis and probable pancreatitis groups were
assessed (r = 0.01, P = .9).
4 | DISCUSSION
The diagnosis of pancreatitis in cats remains difficult because of a lack
of a gold standard test against which diagnostic modalities can be
compared.6 Many authors have suggested that a combination of
diagnostic tests is needed to reach a diagnosis.3,5,11 We retrospec-
tively evaluated the diagnostic utility of the Spec fPL test by using a
multiangle diagnostic approach in 274 cats.
The comparison of positive and negative results in the different
groups of cats in our study showed that the proportion of probable
false positives (ie, cats unlikely to have pancreatitis but with
fPL > 5.3 μg/L) was low at 10%. This frequency may be even lower,
because it was not possible in this group of cats to unequivocally rule
out the presence of pancreatitis at the time of their final diagnosis.
The proportion of false negatives (the proportion of cats with clinical
signs and ultrasonographic changes consistent with pancreatitis but
fPL <3.5 μg/L) was significantly higher at 24%. Therefore, in our popu-
lation of cats, fPL had good diagnostic utility for ruling in the diagnosis
(albeit with some false positives) but lower diagnostic utility in ruling
out the diagnosis, because of the higher proportion of false-negative
results. The cats in our study were assessed at a university teaching
hospital. Therefore, the false-positive and false-negative rates
observed in our study may not apply to other populations in which
the prevalence of pancreatitis is higher or lower.
It was not possible to calculate the sensitivity and specificity of
the fPL test in our study because of the lack of a gold standard test
performed in all cats that would allow the diagnosis to be definitively
TABLE 4 Proportion of cats with
positive (>5.3 μg/L), equivocal
(3.5-5.3 μg/L), and negative (<3.5 μg/L)
fPL results for each of the groups of cats,
n = number of cats
Diagnosis
Positive % (n)
>5.3 μg/L
Equivocal % (n)
3.5-5.3 μg/L
Negative % (n)
<3.5 μg/L
Definite (n = 9) 55.5% (5) 11.1% (1) 33.3% (3)
Probable (n = 49) 67.3% (33) 10.2% (5) 22.4% (11)
Definite and probable (n = 58) 65.5% (38) 10.3% (6) 24.1% (14)
Possible (n = 139) 25.9% (36) 14.4% (20) 59.7% (83)
Unlikely (n = 77) 10.4% (8) 10.4% (8) 79.2% (61)
TABLE 5 Select biochemistry parameters (median values) in the combined definite and probable pancreatitis, possible pancreatitis, and
unlikely pancreatitis groups, n = number of cats
Test Reference range
Combined definite and
probable pancreatitis (n = 58)
Possible pancreatitis
(n = 139)
Unlikely pancreatitis
(n = 77) P value
Albumin 28-42 g/L 31.3 30.5 30.5 .37
ALT 25-130 U/L 60 54 49 .10
ALP 11-58 U/L 34.5 22 23 .05
Calcium 2.07-2.8 mmol/L 2.28 2.29 2.25 .25
TABLE 6 The median, mean, and range of total bilirubin concentration in the combined definite and probable pancreatitis, possible
pancreatitis, and unlikely pancreatitis groups, n = number of cats
Groups
Total bilirubin concentration (μmol/L)
Median Mean Range Comparison between groups
Combined definite and probable
pancreatitis (n = 58)
2.5 15.5 0-194.7 Significantly different from possible pancreatitis
(P = .0005)
Possible pancreatitis (n = 139) 2.5 17.1 0-179.2 Significantly different from combined define and
probable pancreatitis (P = .0005) and unlikely
pancreatitis (P < .0001)
Unlikely pancreatitis (n = 77) 1.9 4.4 0-132.6 Significantly different from possible
pancreatitis (P < .0001)
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ruled in or out. Although histopathological assessment of the pancreas
has been considered the most sensitive diagnostic tool compared to
other diagnostic modalities,2 it can only be utilized to calculate the
sensitivity and specificity of the fPL test if every cat in the study is
biopsied. Histopathological assessment also presents challenges.
In our study, the small number of cats in which the pancreas was
inspected visually or sampled reflects the realities of clinical practice
where pancreatic biopsy is a seldom utilized diagnostic tool because
of its invasive nature and cost. Pancreatic biopsy or cytology can be
contraindicated in severe acute pancreatitis because of the invasive-
ness of the procedure.12 In addition, a surgeon suitably skilled to per-
form the biopsy may not be available, obtaining client consent may be
difficult, and the progression of disease or presence of other concur-
rent diseases could considerably limit the diagnostic value of histopa-
thology.2,3 Moreover, pancreatic lesions can be focal and therefore
normal histopathology result does not necessarily rule out the diagno-
sis.12 In addition, a tissue sample with microscopic pancreatic changes
does not always correlate with the presence of clinical disease.12
There is also a lack of standardized histopathological grading for pan-
creatitis in cats.5,13 In addition, histopathologic evidence of pancreati-
tis has been found in 45% of apparently healthy cats,4 which presents
challenges in interpreting the clinical relevance of pancreatic inflam-
mation, especially if mild. Thus, in practice, after consideration of the
advantages and disadvantages of pancreatic biopsy, and often the
need for immediate treatment of the patient, most cases, as in our
study, do not usually involve this diagnostic procedure.14
Regardless, sensitivity and specificity of fPL have been reported
from necropsy studies. One study used histopathological assessment
in 60 cats presented for necropsy as a reference standard.15 The sen-
sitivity and specificity of the Spec fPL test in that study (with 5.3 μg/L
as upper reference range limit) ranged from 42.1 to 61.1% and 69.0 to
100%, respectively, depending on whether up to 10% lymphocytic
inflammation was considered normal or abnormal. In another study,
histopathological assessment also was used as a reference standard.16
The sensitivity and specificity of the Spec fPL test in that study were
67 and 91%, respectively, indicating, as in the previous study,15 that a
positive result had a high probability of being a true positive but a
negative result could not be used to rule out the diagnosis. This con-
clusion is similar to the conclusion drawn from our study, albeit using
a different method of analysis.
In our study, abdominal ultrasonography was performed in all cats
and changes consistent with pancreatitis were required to classify a
cat as having definite or probable pancreatitis. Abdominal ultrasonog-
raphy is both less expensive and less invasive than pancreatic biopsy.
In 1 study, it was reported to have a sensitivity of 84% and a specific-
ity of 75% for the diagnosis of pancreatitis in cats.17 However, in that
study serum fPL was used as the standard to confirm pancreatitis,
despite the fact that validation of the diagnostic utility of the fPL test
is limited.12 In another study,16 in which histopathology was used to
confirm the diagnosis of pancreatitis, the sensitivity of abdominal
ultrasound examination was 67% and its specificity was 88%.
An additional complication is that the sensitivity and specificity of
ultrasound imaging are highly dependent on the skill and experience
of the ultrasonographer.1,3,5 Therefore, published results of studies
performed at referral institutions may not be as relevant to ultrasono-
graphic studies performed in general practice by nonspecialists. In
addition, there is no standardized ultrasonographic grading scheme
for pancreatitis in cats, and as a result, ultrasonographic interpreta-
tions can be very variable among clinicians.18,19 Several studies have
reported relatively low sensitivity of ultrasonographic diagnosis in cats
with pancreatitis,16,20,21 indicating that a normal abdominal ultrasound
examination does not rule out the diagnosis.
Assessing the sensitivity and specificity of the ultrasonographic diag-
nosis of pancreatitis was not the focus of our study. However, 36 cats in
the possible pancreatitis group and 8 cats in the unlikely pancreatitis
group had positive fPL results including several with very high results
(more than twice the upper reference range). It therefore is feasible that
some, if not many, of these cats did indeed have pancreatitis (either as
their primary disease or a comorbidity) but negative ultrasonographic
findings. Our results highlight the need to combine the Spec fPL test with
abdominal ultrasound findings to help improve the diagnosis of pancrea-
titis in cats, because both tests are useful (but not infallible) in confirming
the diagnosis if positive but neither test can rule out the diagnosis.
A secondary aim of our study was to review the clinical signs
reported in cats suspected to have pancreatitis and to evaluate
changes in selected biochemical tests in the diagnostic assessment of
cats that may have pancreatitis. As Table 2 indicates, the most com-
mon clinical signs seen in all groups were lethargy, anorexia, vomiting,
and weight loss, indicating that clinical findings are not reliable for dif-
ferentiating pancreatitis from nonpancreatic disease.
Hypoalbuminemia, increased ALT and ALP activities, hyper-
bilirubinemia and hypocalcemia are reported as potential serum bio-
chemical abnormalities in cats with pancreatitis.1,5,11,14 Significant
differences in serum albumin concentrations have been reported in cats
with moderate to severe pancreatitis compared with healthy cats and
cats with mild pancreatitis,16 a finding not replicated in our study of a
much larger cohort of cats (n = 274 versus n = 29).16 Although signifi-
cant differences in serum bilirubin concentrations were found among
groups in our study, it was not diagnostically helpful because no signifi-
cant difference in bilirubin concentrations was found between in cats in
the definite or probable pancreatitis group and those in the unlikely
pancreatitis group. No correlation was found between fPL and serum
bilirubin concentration. No significant differences were found among
groups in the other biochemical tests, a finding similar to a previous
study.16
Our study had several limitations. It was a retrospective study con-
ducted on a population of sick cats assessed and treated at a specialist
referral hospital. The cases were a mixture of first opinion cases that
entered through our first opinion emergency service and referral cases,
but the proportion of each type of case could not be determined.
Unfortunately, in only a small number of cats (n = 9) was pancreatitis
confirmed visually, cytologically, or histopathologically (definite pancre-
atitis). However, a large group of cats (n = 58) had clinical signs and
ultrasonographic changes consistent with pancreatitis (definite + proba-
ble pancreatitis group), and thus the diagnostic performance of fPL in
this group of cats was clinically relevant.
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In conclusion, our study supported the use of Spec fPL as part of
the diagnostic evaluation of cats with suspected pancreatitis. How-
ever, our results must be interpreted with caution. A positive result
increases the likelihood of the diagnosis, because in our study and
others, the false-positive rate appears to be low. It cannot, however,
be used to rule out pancreatitis as a diagnosis because the false-
negative rate is relatively high. Approximately 25% of the cases classi-
fied as definite or probable pancreatitis in our study would have been
missed if Spec fPL was the only diagnostic test used. Pancreatitis in
cats remains a challenge to diagnose, and results from multiple diag-
nostic modalities should be assessed when making the diagnosis.
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